Form4insider filings, from the source

SEC Form 3 · accession 0000899243-16-011840

Mirati Therapeutics, Inc. · MRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 14, 2016
Accepted (ET)
Jan 15, 2016 · 6:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———3,591D
Common StockF2holding———1,232,093ISee Footnote
Common StockF3holding———429,340ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to purchase)F2,F4$7.86holding————Nov 21, 2017Common Stock189,780—D
Warrant (right to purchase)F5,F4$7.86holding————Nov 21, 2017Common Stock78,186—D

Explanation of responses